Dihydrofolate Reductase anticorps (AbBy Fluor® 594)
Aperçu rapide pour Dihydrofolate Reductase anticorps (AbBy Fluor® 594) (ABIN2808570)
Antigène
Voir toutes Dihydrofolate Reductase (DHFR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human DHFR
-
Isotype
- IgG
-
-
-
-
Indications d'application
- FCM(1:20-100), IF(IHC-P)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at 4°C
-
Date de péremption
- 12 months
-
-
- Dihydrofolate Reductase (DHFR)
-
Autre désignation
- DHFR
-
Sujet
-
DHFR catalyzes the NADPH-dependent reduction of dihydrofolate to tetrahydrofolate, and is a crucial enzyme for the synthesis of purines, pyrimidines and some amino acids. Inhibition of the activity of this enzyme leads to arrest of DNA synthesis and cell death. Gene expression of methotrexate (MTX)-resistant variants of DHFR in normal hematopoietic cells is a potential strategy to permit administration of larger doses of MTX by alleviating drug toxicity in normal cells and tissues that are drug sensitive.
Synonyms: DHFR, DHFRP1, Dihydrofolate reductase, DYR, DYR_HUMAN, EC 1.5.1.3. -
ID gène
- 1719
-
Pathways
- Mitotic G1-G1/S Phases
Antigène
-